What one share of Oric Pharmaceuticals holds
Profound advancements in oncology drug development have expanded the treatment options available to patients, yet therapeutic resistance and relapse continue to limit the efficacy and duration of clinical benefit of such treatments.
Oric Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.35 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.08 |
| Cash and investments | $0.36 |
| Book value | $3.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$12.32 | $0.30 | −$12.23 | — | −$37.15 |
| 2019 | — | −$14.15 | $0.40 | −$12.79 | — | −$45.40 |
| 2020 | — | −$3.36 | $0.03 | −$2.09 | — | $7.90 |
| 2021 | — | −$2.07 | $0.02 | −$1.59 | — | $6.92 |
| 2022 | — | −$2.25 | $0.05 | −$1.95 | — | $4.93 |
| 2023 | — | −$1.96 | $0.02 | −$1.68 | — | $4.08 |
| 2024 | — | −$1.83 | $0.02 | −$1.63 | — | $3.42 |
| 2025 | — | −$1.47 | $0.01 | −$1.27 | — | $3.90 |
Common questions about Oric Pharmaceuticals
How much does one share of Oric Pharmaceuticals earn?
Over the last 12 months, Oric Pharmaceuticals lost $1.35 for each share.
Does Oric Pharmaceuticals pay a dividend?
Oric Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Oric Pharmaceuticals’s book value per share?
Oric Pharmaceuticals’s book value is $3.68 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Oric Pharmaceuticals have?
Each share of Oric Pharmaceuticals has $0.36 of cash and investments, as of June 30, 2026.
What is Oric Pharmaceuticals’s free cash flow per share?
−$1.08 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Oric Pharmaceuticals bought back shares?
Oric Pharmaceuticals’s share count rose about 4963% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.